Projects per year
Personal profile
Biography
I am an Associate Professior at Macquarie University and a medical oncologist, I have interests in lung, gastrointestinal and breast cancers and have been treating patients with disease for more than a decade. I also hold a mater degrees in Medicine and my reaserch on some molecular changes in lung cancer. I have alos worked in clinical genetics in addition to my oncology training. I teach at the MD programme and lecturing year 1 and 2 medical students . The topics are management of cancer, beyond chemotherapy, cancer genetics, lung cancer, I also contribute to bed site teaching. I am the head of medical oncology disciline and heavily involved in clinical reasearch conducted at MUH. I am focus on the novel agnets with potetnial anti cancer effect and use these agents in phase 1, 2 and 3 trials. We also have close collaboration with laboratory based research in developing new anti cancer treatemnts. I look forwarding to doing more reserach and teaching, bringing to life the MUH mission of heal, learn and discover.
Fingerprint
- 1 Similar Profiles
-
CTU: A Randomized, Double-blinded, Multicenter, Phase Ⅲ Clinical Study of HLX22 (Recombinant Humanized Anti-HER2 Monoclonal Antibody Injection) in Combination with Trastuzumab and Chemotherapy (XELOX) versus Trastuzumab and Chemotherapy (XELOX) with or without Pembrolizumab for the First Line Treatment of Locally Advanced or Metastatic Gastroesophageal Junction and Gastric Cancer
Poursoltan, P. (Primary Chief Investigator), Quinlan, G. (Clinical Trial Unit Staff), Martin, L. (Clinical Trial Unit Staff), Garcia, M. (Clinical Trial Unit Staff), Armstrong, E. (Clinical Trial Unit Staff), Chik, J. (Clinical Trial Unit Staff) & Chapman, N. (Clinical Trial Unit Staff)
4/03/25 → 15/01/30
Project: Research
-
OXTOX: Can Oxaliplatin dose reduction and neurotoxicity be reduced with ibudilast in people with metastatic colorectal cancer – a phase II randomised study
Moth, E. (Primary Chief Investigator), Poursoltan, P. (Associate Investigator) & Chapman, N. (Clinical Trial Unit Staff)
2/11/21 → 1/10/26
Project: Research
-
Speckle-tracking Global Longitudinal Strain (GLS) for Early Detection of Cardiotoxicity from Anticancer Therapy
Brown, M. (Primary Chief Investigator), Al-Zubaidi, K. (Primary Chief Investigator), Gilchrist, J. (Associate Investigator), Kefford, R. (Associate Investigator), Gurney, H. (Associate Investigator) & Poursoltan, P. (Associate Investigator)
Project: Research
-
IMbrave050: A phase III, multicentre, randomized, open-label study of atezolizumab (anti-PD-L1 antibody) plus bevacizumab plus bevacizumab versus active surveillance as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after surgical resection or ablationR SURGICAL RESECTION OR ABLATION
Poursoltan, P. (Primary Chief Investigator), Chapman, N. (Clinical Trial Unit Staff) & Parshionikar, A. (Clinical Trial Unit Staff)
11/12/19 → 30/09/24
Project: Other
-
DYNAMIC III: Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colon Cancer: A Multicentre Phase II/III Randomised Controlled Study
Poursoltan, P. (Primary Chief Investigator), Chapman, N. (Primary Chief Investigator) & Cunningham, J. (Other)
2/05/19 → 1/05/24
Project: Other
-
Thyrotropin secreting pituitary microadenoma and lung adenocarcinoma treated with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) Erlotinib and Osimertinib: a case report
Ieva, A. D., Kim, S. Y., Lewis, D., Poursoltan, P. & Preda, V., 1 Nov 2022, In: Journal of the Endocrine Society. 6, Supplement 1, p. A513-A514 2 p., ODP359 .Research output: Contribution to journal › Meeting abstract › peer-review
Open AccessFile56 Downloads (Pure) -
Safety and tolerability of Miltuximab®: a first in human study in patients with advanced solid cancers
Sabanathan, D., Campbell, D. H., Velonas, V. M., Wissmueller, S., Mazure, H., Trifunovic, M., Poursoltan, P., Shon, K. H., Mackay, T. R., Lund, M. E., Lu, Y., Roach, P. J., Bailey, D. L., Walsh, B. J., Gillatt, D. & Gurney, H., 2021, In: Asia Oceania Journal of Nuclear Medicine and Biology. 9, 2, p. 86-100 15 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus)56 Downloads (Pure) -
Early detection of cardiotoxicity in cancer patients receiving novel chemotherapy and immunomodulation by measuring global longitudinal strain (GLS) with transthoracic echocardiography
Al-zubaidi, K., Brown, M., Gurney, H., Kefford, R. & Poursoltan, P., 2 Sept 2018, In: Heart Lung and Circulation. 27, Supplement 2, p. S94 1 p., 0115.Research output: Contribution to journal › Article › peer-review
-
Primary breast cancer of the vulva: a case report and literature review
Al-Mansouri, L., Poursoltan, P., Simons, M., Muljono, A. & Boyages, J., Dec 2018, In: Journal of Obstetrics and Gynaecology Research. 44, 12, p. 2190-2194 5 p.Research output: Contribution to journal › Article › peer-review
6 Citations (Scopus) -
MILGa-01: a first-in-human study assessing the safety and tolerability of chMIL-38 in metastatic prostate, bladder, and pancreatic cancers
Gurney, H., Sabanathan, D., Gillatt, D., Poursoultan, P., Ho Shon, K., Walsh, B., Velonas, V., Thurecht, K. & Campbell, D., 2017, In: Journal of Clinical Oncology. 35, 6, 1 p., e565.Research output: Contribution to journal › Meeting abstract